Rare diseases
Investigational molecules
Locations
Universitetstorget 4, Alidhem, 907 36 Umea, Sweden
Umea University in Umea, Sweden specialises in clinical trials of conditions such as Amyotrophic lateral sclerosis, Dementia Alzheimer's type, and other specialisations. This site conducts important research.
The medical center is at the forefront of Amyotrophic Lateral Sclerosis (ALS) research, focusing on innovative therapeutic approaches to address this challenging neurodegenerative condition. The center's research is dedicated to exploring the safety and potential efficacy of novel treatments, such as AMT-162, for individuals diagnosed with SOD1 ALS.
Through its commitment to advancing the understanding and treatment of ALS, the center contributes significantly to the development of new clinical applications that aim to improve patient outcomes and quality of life.
Clinical trials registered at this site – none is enrolling right now.
A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy
SwedenStudy on the Safety and Effects of AMT-162 Gene Therapy for Adults with SOD1 ALS
SwedenGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
